Ogenix markets and sells the EPIFLO^® line of Class 3 medical devices used for treatment of various wounds as indicated by the FDA. Ogenix has received a 510K marketing clearance by the FDA and is also cleared in Canada by Health Canada. EPIFLO^® has been used by doctors, hospitals, skilled nursing facilities, and long term care facilites for treatment of Bed Sores (Decubitus Ulcers) and by Podiatrists and Physicians for the treatment of chronic lower extremity wounds such as Diabetic Foot Ulcers and Venous Leg Ulcers (Venous Stasis).

EPIFLO is manufactured in the USA at an FDA regulated, ISO 13485 certified facility in Ohio.